BioCentury
ARTICLE | Clinical News

GeoVax Labs preclinical data

September 21, 2015 7:00 AM UTC

In guinea pigs and hamsters, GOVX-E301 conferred 100% protection against Ebola virus infection. GeoVax said it is planning a challenge study in non-human primates of the recombinant modified vaccinia ...